Jan

10

Editas Medicine Reports on Recent Progress and Outlook at J.P. Morgan Healthcare Conference

Jan

4

Editas Medicine to Present at the 40th Annual J.P. Morgan Healthcare Conference

Dec

20

Editas Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for EDIT-301 for the Treatment of Transfusion-Dependent Beta Thalassemia